%0 Journal Article
%T The feasibility of high dose chemotherapy with autologous stem cell transplantation for multiple sclerosis
%A Evgeny P. Evdoshenko
%A Lyudmila S. Zubarovskaya
%A Leonid G. Zaslavsky
%A Alexander A. Skoromets
%J Cellular Therapy and Transplantation
%D 2011
%I 
%X The results of observing 23 patients with multiple sclerosis who received autologous hematopoietic stem cell transplantation are shown in this article. The risks of an auto-HSCT and its advantages compared with other therapy methods, and also an optimal choice for the therapy predictors are discussed. The results show progress of disease in most cases after 12¨C18 months.
%K autologous hematopoietic stem cell transplantation (auto-HSCT)
%K multiple sclerosis
%U http://www.ctt-journal.com/2-6-en-evdoshenko-e-a-2011mar22.html